-+ 0.00%
-+ 0.00%
-+ 0.00%

Jones Trading Initiates Coverage On AbCellera Biologics with Buy Rating, Announces Price Target of $11

Benzinga·04/10/2026 12:20:34
Listen to the news
Jones Trading analyst Debanjana Chatterjee initiates coverage on AbCellera Biologics (NASDAQ:ABCL) with a Buy rating and announces Price Target of $11.